Faculty profile

Eugenia Oviedo-Joekes

ResearcherSchool of Population and Public HealthUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Eugenia Oviedo-Joekes

Researcher

School of Population and Public Health

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
20 publications in the last five years, latest in 2026.
Senior (last) author on 14 recent papers, a sign of leading a research group.
Principal investigator on 9 research grants (9 CIHR), most recently in 2023.
Supervised 4 trainees who won CIHR awards, most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Injectable Opioid Agonist Treatment Opioid Use Disorder Opioid-Dependence Opioid Dependence Accessibility Disability Providers Crc

Latest papers

Substance use disorders and related hospitalizations and mortality among gay, bisexual, and other men who have sex with men: A matched cohort study.
Drug and alcohol dependence · 2026
Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short-Acting Injectable Opioid Treatment in Australia.
Drug and alcohol review · 2025
Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in Australia.
The International journal on drug policy · 2025

All 71 publications

Latest funding

Forging Community from Chaos: Advancing Equitable Health Outcomes in Complex Care Populations - A Comprehensive Study of the Dr. Peter Centre's Holistic Approach and Model of Care
CIHR · 2024 · Co-investigator
$20,000
Program of Outcomes Research on Treatment with Injectables for Addiction: Accessibility Needs and Tangible Actions
CIHR · 2023 · Nominated PI
$100,000
The Cedar Project: Strengthening Our Spirit Intervention for Indigenous peoples who use drugs in Vancouver, BC
CIHR · 2023 · Co-investigator
$1,977,524

All 22 grants and awards

71 publications.

Substance use disorders and related hospitalizations and mortality among gay, bisexual, and other men who have sex with men: A matched cohort study.

Aguilera-Mijares S, Wang L, Trigg J, Hogg RS, Lachowsky N, Gormezano A, Sereda P, Card K, Oviedo-Joekes E, Emerson SD, Lal A, Budu M, Hart TA, Cox J, Grace D, Tan DHS, Moore DM

Drug and alcohol dependence2026

DOI: 10.1016/j.drugalcdep.2026.113159 PMID: 41980572

Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short-Acting Injectable Opioid Treatment in Australia.

Rance J, Belackova V, Bell J, Dunlop AJ, Ezard N, Jauncey M, Lintzeris N, Oviedo-Joekes E, Ritter A, Roberts DM, Rodgers C, Siefried KJ, Strang J, van den Brink W, Treloar C

Drug and alcohol review2025

DOI: 10.1111/dar.14092 PMID: 40457846

Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in Australia.

Ritter A, Bell J, Strang J, Ezard N, Rodgers C, Belackova V, Jauncey M, Siefried KJ, Roberts DM, van den Brink W, Lintzeris N, Dunlop A, Oviedo-Joekes E, Treloar C

The International journal on drug policy2025

DOI: 10.1016/j.drugpo.2025.104749 PMID: 40037105

Building Capacity for Injectable Diacetylmorphine and Hydromorphone for the Treatment of Opioid Use Disorder: Identifying Typical Doses.

Magel T, Arreola LAG, Guh D, MacDonald S, Harrison S, Schechter M, Oviedo-Joekes E

Journal of psychoactive drugs2025Senior author

DOI: 10.1080/02791072.2024.2338734 PMID: 38590251

Oral and injectable opioid agonist treatments for people who use street opioids: a systematic literature review and network meta-analysis.

Bansback N, Tam ACT, Palis H, Kanters S, Popoff E, Schechter MT, Anis AH, Marsh DC, Oviedo-Joekes E

BMC public health2025Senior author

DOI: 10.1186/s12889-025-24365-w PMID: 40885969

Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost.

Rodgers C, Siefried KJ, Ritter A, Belackova V, Treloar C, Jauncey M, Ezard N, Roberts D, Steele M, van den Brink W, Strang J, Oviedo-Joekes E, Lintzeris N, Dunlop AJ, Bell J

BMJ open2024

DOI: 10.1136/bmjopen-2023-082553 PMID: 39097309

Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT).

Beaumont S, Magel T, MacDonald S, Harrison S, Schechter M, Oviedo-Joekes E

Substance abuse treatment, prevention, and policy2024Senior author

DOI: 10.1186/s13011-023-00585-4 PMID: 38172882

Client preferences for the design and delivery of injectable opioid agonist treatment services: Results from a best-worst scaling task.

Metcalfe RK, Dobischok S, Bansback N, MacDonald S, Byres D, Lajeunesse J, Harrison S, Koch B, Topping B, Brock T, Foreman J, Schechter M, Oviedo-Joekes E

Addiction (Abingdon, England)2024Senior author

DOI: 10.1111/add.16620 PMID: 39054406

Neonatal abstinence syndrome and infant mortality and morbidity: a population-based study

Lisonkova S, Wen Q, Richter LL, Ting JY, Lyons J, Mitchell-Foster S, Oviedo-Joekes E, Muraca GM, Bayrampour H, Cattoni E

Frontiers in Pediatrics20246 citations

DOI: 10.3389/fped.2024.1394682

Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling).

Dobischok S, Metcalfe R, Matzinger E, Palis H, Marchand K, Harrison S, MacDonald S, Byres D, Schechter M, Bansback N, Oviedo-Joekes E

The International journal on drug policy2023Senior author

DOI: 10.1016/j.drugpo.2022.103948 PMID: 36586152

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2023

Subject: Prospective PhD student: Injectable Opioid Agonist Treatment Dear Professor Oviedo-Joekes, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Substance use disorders and related hospitalizations and mortality among gay, bisexual, and other men who have sex with men: A matched cohort study." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Program of Outcomes Research on Treatment with Injectables for Addiction: Accessibility Needs and Tangible Actions" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Eugenia Oviedo-Joekes

Research

Latest papers

Latest funding

Substance use disorders and related hospitalizations and mortality among gay, bisexual, and other men who have sex with men: A matched cohort study.

Hydromorphone Hopes: A Qualitative Study of People Initiating Supervised Short-Acting Injectable Opioid Treatment in Australia.

Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in Australia.

Building Capacity for Injectable Diacetylmorphine and Hydromorphone for the Treatment of Opioid Use Disorder: Identifying Typical Doses.

Oral and injectable opioid agonist treatments for people who use street opioids: a systematic literature review and network meta-analysis.

Implementation of time-limited parenteral hydromorphone in people with treatment-resistant injecting opioid use disorder: a protocol for a single-site, uncontrolled, open-label study to assess feasibility, safety and cost.

Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT).

Client preferences for the design and delivery of injectable opioid agonist treatment services: Results from a best-worst scaling task.

Neonatal abstinence syndrome and infant mortality and morbidity: a population-based study

Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling).

Frequent collaborators

Scott Harrison

Kirsten Marchand

Heather Palis

Kurt Lock

Bohdan Nosyk

Martin Schechter

Aslam Anis

David Byres

Jill Chettiar

Patricia Spittal

Sheona Mitchell-Foster

Sarka Lisonkova

Giulia Muraca

Nathan Lachowsky

Mohammad Karamouzian

Nathan Lachowsky

Azar Mehrabadi

Kiffer Card

Patrick McDougall

Kate Jongbloed

Aki Gormezano

Josie Geller

Hamideh Bayrampour